Loading…
Loading…
NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of STAAR Surgical Company (NASDAQ: STAA) concerning possible breaches of fiduciary duties. If you are a current shareholder of STAA, you can request additional information here: https://zlk.com/cases/staar-surgical-company-class-action-lawsuit-staa-3 or contact Joseph E.
B. Riley Wealth Advisors Inc. bought a new stake in STAAR Surgical Company (NASDAQ: STAA) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 24,160 shares of the medical instruments supplier's stock, valued at approximately $546,000. A number of other institutional investors
STAAR Surgical Company (âSTAARâ or the âCompanyâ) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointment of Andrew Pilon, O.D. as Vice President of Business Development. Dr. Pilon will report to STAAR President and Chief Executive Officer Warren Foust and will work closely with the Company's senior leadership team to capitalize on opportunities th.
That pundit now believes it's a buy. He cited positive sales momentum, especially in a key market overseas.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Markets opened Tuesday on edge as surging oil prices, climbing Treasury yields, and a rejected Iran ceasefire rattled traders heading into the final stretch of Q3. Find out which major names on Wall Street got upgraded, downgraded, or freshly initiated before the opening bell.
Sensus Healthcare (NASDAQ: SRTS - Get Free Report) and STAAR Surgical (NASDAQ: STAA - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, valuation, profitability, dividends, risk and analyst recommendations. Analyst Ratings This is a breakdown of